Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Norton

Showing results (431-440 of 523) with videos related to

Pageof 53
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662D F Hayes, H Yamauchi, G Broadwater, et al.
Oncogene|July 4, 2012
p21CIP1 mediates reciprocal switching between proliferation and invasion during metastasisX Qian, J Hulit, K Suyama, et al.
Journal of the National Cancer Institute|August 27, 1998
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group BD R Budman, D A Berry, C T Cirrincione, et al.
The Annals of Thoracic Surgery|December 27, 2019
Influence of Age on Longevity of a Stentless Aortic ValveBo Yang, Aroosa Malik, Linda Farhat, et al.
Journal of Translational Medicine|November 12, 2020
Bronchoalveolar Tregs are associated with duration of mechanical ventilation in acute respiratory distress syndromeDustin L Norton, Agathe Ceppe, Miriya K Tune, et al.
Science (New York, N.Y.)|February 6, 2025
In Science JournalsIan S Osborne, Madeleine Seale, Corinne Simonti, et al.
Science (New York, N.Y.)|February 20, 2025
In Science JournalsMarc S Lavine, Michael A Funk, Jake S Yeston, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 2011
A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancerM N Fornier, P G Morris, A Abbruzzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: feasibility and efficacyC Hudis, A Seidman, J Baselga, et al.
Oncogene|August 27, 2013
N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like propertiesX Qian, A Anzovino, S Kim, et al.
Pageof 53

Showing results (431-440 of 523) with videos related to

Sort By:
Pageof 53
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662D F Hayes, H Yamauchi, G Broadwater, et al.
Oncogene|July 4, 2012
p21CIP1 mediates reciprocal switching between proliferation and invasion during metastasisX Qian, J Hulit, K Suyama, et al.
Journal of the National Cancer Institute|August 27, 1998
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group BD R Budman, D A Berry, C T Cirrincione, et al.
The Annals of Thoracic Surgery|December 27, 2019
Influence of Age on Longevity of a Stentless Aortic ValveBo Yang, Aroosa Malik, Linda Farhat, et al.
Journal of Translational Medicine|November 12, 2020
Bronchoalveolar Tregs are associated with duration of mechanical ventilation in acute respiratory distress syndromeDustin L Norton, Agathe Ceppe, Miriya K Tune, et al.
Science (New York, N.Y.)|February 6, 2025
In Science JournalsIan S Osborne, Madeleine Seale, Corinne Simonti, et al.
Science (New York, N.Y.)|February 20, 2025
In Science JournalsMarc S Lavine, Michael A Funk, Jake S Yeston, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 2011
A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancerM N Fornier, P G Morris, A Abbruzzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: feasibility and efficacyC Hudis, A Seidman, J Baselga, et al.
Oncogene|August 27, 2013
N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like propertiesX Qian, A Anzovino, S Kim, et al.
Pageof 53